Zidovudine Does It Work for Everyone?

JAMA: The Journal of the American Medical Association

Volumn 266, Issue 19, 1991, Pages 2750-2751

  Smith, Mark D ^a  

^a HENRY J KAISER FAMILY FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DRUG EFFICACY; EDITORIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; RACE DIFFERENCE; UNITED STATES;

ACQUIRED IMMUNODEFICIENCY SYNDROME; FEMALE; HISPANIC AMERICANS; HIV INFECTIONS; HUMAN; MALE; NEGROID RACE; ZIDOVUDINE;

EID: 0025719548     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1991.03470190098037     Document Type: Article

References (15)

1. US AIDS cases reported through August 1991. HIV/AIDS Surveillance. Atlanta, Ga: Centers for Disease Control; September 1991.
2. Hamilton JD, Hartigan PM, Simberkoff MS, and the VA Cooperative Study Group, Department of Veterans Affairs. Early vs later zidovudine treatment of symptomatic HIV infection. Clin Res. 1991;39:216A.
3. Lagakos S, Fischl MA, Stein DS, Lim L, Volberding P. Effects of zidovudine therapy in minority and other subpopulations with early HIV infection. JAMA. 1991;266:2709-2712.
4. Easterbrook PJ, Keruly JC, Creagh-Kirk T, et al. Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. JAMA. 1991;266:2713-2718.
5. Volberding PV, Lagakos SW, Koch MA, et al. Zidovudine in asymptomatic human immunodeficiency virus infections: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. N Engl J Med. 1990;322:941-949.
6. Fischl MA, Richman DD, Hansen H, et al. The safety and efficacy of zidovudine in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. Ann Intern Med. 1990;112:727-737.
7. Svensson CK. Representation of American blacks in clinical trials of new drugs. JAMA. 1989;261:263-265.
8. Fauci AS. AIDS: challenges to basic and clinical biomedical research. Acad Med. 1989;64:115-119.
9. Jones JH. Bad Blood: The Tuskegee Syphilis Experiment. New York, NY: Free Press; 1981.
10. Kalow W, Goedde HW, Agarwal DP, eds. Ethnic Differences in Reactions to Drugs and Xenobiotics. New York, NY: Alan R Liss Inc; 1986.
11. Short PF, Cornelius LJ, Goldstone DE. Health insurance of minorities in the United States. J Health Care Poor Underserved. 1990;1:9-24.
12. Blendon RJ, Aiken LH, Freeman HE, Corey CR. Access to medical care for black and white Americans. JAMA. 1989;261:278-281.
13. Nickens HW. The health status of minority populations in the United States. West J Med. 1991;155:27-32.
14. Moore RD, Hidalgo J, Sugland BW, Chaisson RE. Zidovudine and the natural history of AIDS. N Engl J Med. 1991;324:1412-1416.
15. Smith MD. Primary care and HIV disease. J Gen Intern Med. 1991;6:S56-S62.